EUROPEAN CYSTIC FIBROSIS SOCIETY – CLINICAL TRIALS NETWORK ECFS-CTN reporting to patients 2014 European Cystic Fibrosis Society – Clinical Trials Network
[email protected] ECFS-CTN reporting to patients 2014 Content GENERAL REPORTING: ............................................................................................................................................ 3 1. WHY ARE CLINICAL TRIALS IMPORTANT? ..................................................................................................................... 3 2. WHAT IS THE ECFS-CTN AND WHICH SITES ARE INVOLVED? ........................................................................................... 3 3. WHAT DOES THE ECFS-CTN DO? ............................................................................................................................. 4 4. WHAT IS THE DIRECT AND POTENTIAL BENEFIT TO PATIENTS? .......................................................................................... 8 5. ECFS-CTN FINANCIAL SUPPORT ............................................................................................................................... 8 6. WHY DOES THE ECFS-CTN NEED YOUR SUPPORT AND WHAT CAN YOU DO TO SUPPORT ECFS-CTN? .................................... 9 2014 ANNUAL REPORTING ................................................................................................................................... 11 1. PARTICIPATING SITES, GOVERNANCE, COMMITTEES ....................................................................................................